BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 38546086)

  • 1. Evaluation of IP3R3 Gene Silencing Effect on Pyruvate Dehydrogenase (PDH) Enzyme Activity in Breast Cancer Cells with and Without Estrogen Receptor.
    Vaseghi G; Shariati L; Bahri Najafi M; Malakootikhah Z; Naji Esfahani H; Haghjooy Javanmard S
    Adv Biomed Res; 2024; 13():24. PubMed ID: 38808320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
    Thulasiraman P; McAndrews DJ; Mohiudddin IQ
    BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation.
    Zhao F; Ming J; Zhou Y; Fan L
    Cancer Chemother Pharmacol; 2016 May; 77(5):963-72. PubMed ID: 27011212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells.
    Chen WC; Lai YA; Lin YC; Ma JW; Huang LF; Yang NS; Ho CT; Kuo SC; Way TD
    J Agric Food Chem; 2013 Dec; 61(48):11817-24. PubMed ID: 24236784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.
    Yao PL; Morales JL; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Mol Cancer Ther; 2014 Apr; 13(4):1008-17. PubMed ID: 24464939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Inhibits the PPARδ-p-Akt-GLUT1 Pathway and Ameliorates the Antiproliferative Effects of Doxorubicin in MDA-MB-231 Cells.
    Thulasiraman P; Foret M; Pandit R; McAlister K
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):1035-1043. PubMed ID: 38546086
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.